Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug
US6267116A · kind A · utility
Assignee
Inventor
Key dates
| Filing date | Jul 6, 1999 |
| Grant date | Jul 31, 2001 |
| Priority date | — |
| Expiry date | Jul 6, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K49/0004
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method and system for use in treating a patient receiving any drug to optimize therapy and to prevent an adverse drug response. This system employs surrogate markers or indicators, including blood levels of drug, to determine the next required dose for a patient. Before surrogate markers are employed as a percent change in status, virtually any indicator can be used. Surrogate markers could include any measure the effectiveness of a drug's action. Given the effectiveness of the drug's action, relative to the surrogate markers, a change in drug dose is calculated by the system. Conversely, by employing this system, one could determine the expected result of a drug dose change on the surrogate markers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.